ARN-3016

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameARN-3016
Drug Alias Nameprotein kinase inhibitor (Arrien Pharmaceuticals)ARN-3016
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnticancer protein kinase inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArrien Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArrien Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A